Related Experiment Video
Updated: Aug 24, 2025

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
Published on: November 22, 2024
[Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians].
V I Simanenkov1, I V Maev2, O N Tkacheva3
1Mechnikov North-Western State Medical University.
This guideline provides evidence-based recommendations for physicians on managing Increased Epithelial Permeability Syndrome. It details epithelial protective drugs like proton pump inhibitors, bismuth drugs, probiotics, and rebamipide.
Area of Science:
- Gastroenterology
- Internal Medicine
- Pharmacology
Context:
- The 2021 National Consensus on Increased Epithelial Permeability Syndrome (IEPS) established a foundation for understanding the condition.
- This document builds upon the 2021 Consensus, offering practical guidance for clinicians.
- Expert consensus was achieved using the Delphi method to develop 28 physician statements.
Purpose:
- To provide evidence-based practical guidelines for physicians managing IEPS.
- To update and expand upon the initial national consensus on IEPS.
- To detail the clinical and pharmacological properties of epithelial protective agents.
Summary:
- The guidelines review key drug classes for epithelial protection, including proton pump inhibitors, bismuth compounds, and probiotics, based on evidence-based medicine.
- Focuses on rebamipide as a comprehensive epithelial protector with pre-epithelial, epithelial, and sub-epithelial actions.
- Covers the entire gastrointestinal tract, offering a unified approach to IEPS management.
Impact:
- Aims to improve clinical practice and patient outcomes in managing IEPS.
- Facilitates consistent and effective application of evidence-based treatments for IEPS.
- Enhances understanding and utilization of epithelial protective therapies in gastroenterology.
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

